Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma

Title
Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Liver Cancer
Volume -, Issue -, Pages 1-7
Publisher
S. Karger AG
Online
2018-08-24
DOI
10.1159/000492534

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search